Utah Medical Products Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -55.4% | +90.0% | -4.2% | -14.0% | +0.4% | +10.1% | -3.7% | +229.4% | -76.5% | +68.2% | -31.1% | +3.9% | -6.9% | -1.0% | +58.8% | +19.3% | -9.2% | +25.0% | -10.3% | +5.3% | +16.4% | -0.4% | +1.3% | +18.1% | +5.3% | -0.3% | +5.4% | -33.4% | -0.9% | |
| – | +7.1% | +40.0% | +4.4% | 0.0% | -11.8% | -39.4% | -16.0% | -17.8% | -16.4% | -6.2% | -5.8% | -1.0% | -0.5% | +3.2% | +356.8% | +17.8% | -2.2% | +5.0% | -6.2% | -10.0% | -2.1% | +6.6% | +132.8% | +4.8% | +1.0% | -2.8% | -10.1% | -55.3% | +5.7% | |
| – | – | – | – | – | – | – | – | – | – | -260.4% | – | – | -18.3% | -15.3% | +14.5% | -26.3% | -60.0% | +164.3% | +17.6% | +5.7% | +40.2% | -50.4% | +76.6% | +41.6% | +3.8% | +10.2% | +23.0% | +13.8% | +45.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,050.0% | – | -130.8% | – | – | – | – | – | – | +0.0% | -232.8% | – | – | – | |
| – | -240.0% | – | -27.0% | -84.4% | -149.0% | – | – | – | -115.7% | – | -128.6% | – | +848.1% | +89.1% | +222.7% | -69.5% | -296.2% | – | -134.2% | – | – | -165.9% | – | – | -150.5% | – | – | – | – | |
| – | -79.7% | +291.7% | -85.4% | -47.2% | +45.2% | -1.3% | -23.8% | +6.9% | -18.1% | -3.2% | +7.8% | -20.3% | +65.2% | +223.6% | -83.3% | -0.4% | +34.9% | +229.1% | -78.3% | +1,242.3% | -51.6% | -74.8% | +5,258.2% | -96.0% | -35.8% | +48.2% | -21.9% | -63.2% | +57.9% | |
| – | -1,037.5% | -33.3% | -86.3% | -12.4% | -12.7% | -1.3% | +99.8% | +1,384.4% | -87.6% | +38.7% | -87.2% | – | -165.0% | – | -1,086.5% | -99.2% | +65.4% | +229.1% | -78.3% | +1,242.3% | -51.6% | – | -4,133.7% | -96.0% | -35.8% | +48.2% | -21.9% | -67.4% | +78.4% | |
| – | – | – | – | – | – | – | – | – | +83.7% | +18.7% | +18.0% | +26.5% | -22.9% | +80.7% | -43.1% | +3.6% | +3.4% | +2.4% | +2.2% | +1.8% | -24.5% | +36.2% | +2.1% | +0.1% | +178.5% | -72.4% | +35.4% | -0.5% | -6.5% | |
| – | -63.0% | -68.5% | +609.3% | -3.8% | -98.3% | +6,023.3% | -76.3% | +282.8% | -11.8% | -49.2% | -57.8% | +285.2% | -98.5% | +278.4% | – | -101.9% | -83.1% | +1,141.2% | -35.3% | +317.3% | +0.0% | -57.7% | -67.0% | +1,652.8% | +0.0% | -64.2% | +0.0% | +700.3% | -58.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -66.2% | -143.0% | +3.2% | +18.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1,125.0% | +122.4% | -18.3% | -1.0% | +11.8% | -16.7% | +58.9% | -47.9% | +42.9% | -20.7% | +113.7% | -72.6% | +70.3% | – | -161.8% | -40.9% | +25.2% | +7.6% | -28.7% | -58.2% | +80.1% | -11.5% | +153.9% | +1.6% | -49.7% | -24.1% | +472.3% | -48.2% | |
| – | – | -1,125.0% | – | – | – | – | – | +121.4% | -205.6% | – | – | -280.0% | – | +988.8% | -20.3% | -14.0% | +136.4% | -11.7% | -17.9% | -24.6% | +349.9% | -17.2% | -174.1% | – | +6.6% | +50.0% | +26.6% | -155.5% | – | |
| – | -28.3% | +26.3% | +75.4% | -11.3% | -1.7% | +10.9% | -2.4% | +240.5% | -77.4% | +72.3% | -32.4% | +5.1% | -9.7% | -16.7% | +97.6% | +19.8% | -10.1% | +19.1% | -4.9% | -17.2% | +36.4% | +7.3% | -127.3% | – | +7.1% | -1.6% | +6.5% | -32.6% | -1.9% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.